Form 4: Oracle Director Naomi Seligman Sells Shares Under Pre-Arranged Plan
Insider Transaction Report
Oracle Corporation Director Naomi O. Seligman sold 3,303 shares of common stock at $233.32 per share, a transaction executed under a Rule 10b5-1 pre-planned trading arrangement.
Summary
- Naomi O. Seligman, a Director of Oracle Corporation (ORCL), disposed of 3,303 shares of common stock.
- The transaction occurred on July 16, 2025, at a price of $233.32 per share.
- The sale was conducted pursuant to a Rule 10b5-1(c) pre-planned contract, instruction, or written plan.
- Following the reported transaction, Naomi O. Seligman directly owns 31,447 shares of Oracle Common Stock.
- Additionally, Seligman indirectly beneficially owns 6,010 shares through a spouse and 14,414 shares through a trust.
Sentiment
Score: 5
Explanation: Neutral. While a director selling shares can be perceived negatively, the fact that it was executed under a pre-planned Rule 10b5-1 arrangement mitigates concerns, making it a routine and expected event for insider portfolio management.
Positives
- The transaction was executed under a Rule 10b5-1 plan, indicating a pre-scheduled sale rather than a reactive one, which can reduce concerns about insider sentiment.
Negatives
- A director selling shares reduces their direct ownership stake in the company.
Future Outlook
NA
Industry Context
Insider transactions, such as those reported on Form 4, are routine disclosures in the financial industry, providing transparency into how company executives and directors manage their personal holdings. Sales under Rule 10b5-1 plans are common for corporate insiders to diversify their portfolios and manage liquidity while avoiding accusations of trading on material non-public information.
Stakeholder Impact
- Shareholders: May view the director's sale as a slight negative signal, though the Rule 10b5-1 plan context often lessens this impact. It provides transparency into insider holdings.
Key Dates
| Date | Description |
|---|---|
| 07/16/2025 | Date of transaction (sale of common stock) |
| 07/18/2025 | Date the Form 4 was signed by the reporting person's attorney-in-fact |
Keywords
Oracle, ORCL, SEC Form 4, Insider Sale, Director Stock Sale, Naomi O. Seligman, Rule 10b5-1, Common Stock, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.